Advertisement

Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease

      Peripheral vascular disease (PVD) is common in patients referred for transcatheter aortic valve implantation (TAVI). We sought to investigate the impact of PVD on patients who underwent TAVI. Using data from the National Inpatient Sample database 2011 and 2014, we identified patients who had undergone TAVI. We studied the clinical characteristics and procedural outcomes in patients with PVD who underwent TAVI compared with those patients without PVD using propensity score matching score matching. Results: A total of 42,215 patients underwent TAVI; of which 1,388 patients were matched using propensity score matched scores to 694 in each (PVD vs no PVD) patients. The population had a mean age of 81 years old and 55.8% were of female gender. African-Americans constituted 4.3%. PVD patients who underwent TAVI were found to have higher rates of vascular complications (11.8% vs 5.9 % p <0.001) compared with non-PVD patients and tended to have higher mortality (5.5% vs 3.6%, p = 0.121) and post-TAVI bleeding (13.5% vs 12% p = 0.143). In conclusion, PVD patients have higher in-hospital mortality and higher incidence of in-hospital overall complications compared with patients who have no PVD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nkomo VT
        • Gardin JM
        • Skelton TN
        • Gottdiener JS
        • Scott CG
        • Enriquez-Sarano M
        Burden of valvular heart diseases: a population-based study.
        Lancet. 2006; 368: 1005-1011
        • Nishimura RA
        • O'Gara PT
        • Bonow RO
        Guidelines update on indications for transcatheter aortic valve replacement.
        JAMA Cardiol. 2017; 2: 1036-1037
        • Rogers T
        • Thourani VH
        • Waksman R
        Transcatheter aortic valve replacement in intermediate‐and low‐risk patients.
        J Am Heart Assoc. 2018; 7e007147
        • Leon MD, Martin B.
        • Smith M.D., Craig R.
        • Mack M.D., Michael
        • Miller M.D., D.Craig
        • Moses M.D., Jeffrey W.
        • Svensson MD, Ph.D., Lars G.
        • Tuzcu M.D., E.Murat
        • Webb M.D., John G.
        • Fontana M.D., Gregory P.
        • Makkar MD, Raj R.
        • Brown M.D., David L.
        • Block M.D., Peter C.
        • Guyton M.D., Robert A.
        • Pichard MD, Augusto D.
        • Bavaria M.D., Joseph E.
        • Herrmann M.D., Howard C.
        • Douglas M.D., Pamela S.
        • Petersen MD, John L.
        • Akin M.S., Jodi J.
        • Anderson Ph.D., William N.
        • Wang Ph.D., Duolao
        • Pocock PD, Stuart
        Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
        N Engl J Med. 2010; 363: 1597-1607
        • Olin JW
        • Sealove BA
        Peripheral artery disease: current insight into the disease and its diagnosis and management.
        Mayo Clin Proc. 2010; 85: 678-692
        • Tamburino C
        • Capodanno D
        • Ramondo A
        • Petronio AS
        • Ettori F
        • Santoro G
        • Klugmann S
        • Bedogni F
        • Maisano F
        • Marzocchi A
        Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.
        Circulation. 2011; 110 (CIRCULATIONAHA)946533
        • Thomas M.
        A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
        Circulation. 2010; 122: 62-69
        • Fanaroff AC
        • Manandhar P
        • Holmes DR
        • Cohen DJ
        • Harrison JK
        • Hughes GC
        • Thourani VH
        • Mack MJ
        • Sherwood MW
        • Jones WS
        Peripheral artery disease and transcatheter aortic valve replacement outcomes: a report from the society of thoracic surgeons/american college of cardiology transcatheter therapy registry.
        Circ: Cardiovasc Interv. 2017; 10e005456
        • Kamath Ashvin R
        • BA RG
        • PMF
        Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.
        Int J Angiol. 2008; 17: 63-70
        • Thyregod HGH
        • Steinbrüchel DA
        • Ihlemann N
        • Nissen H
        • Kjeldsen BJ
        • Petursson P
        • Chang Y
        • Franzen OW
        • Engstrøm T
        • Clemmensen P
        Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial.
        J Am Coll Cardiol. 2015; 65: 2184-2194
        • Hayashida K
        • Lefèvre T
        • Chevalier B
        • Hovasse T
        • Romano M
        • Garot P
        • Mylotte D
        • Uribe J
        • Farge A
        • Donzeau-Gouge P
        Transfemoral aortic valve implantation: new criteria to predict vascular complications.
        JACC: Cardiovasc Interv. 2011; 4: 851-858
        • Baumann F
        • Husmann M
        • Benenati JF
        • Katzen BT
        • Del Conde I
        Bleeding risk profile in patients with symptomatic peripheral artery disease.
        J Endovasc Ther. 2016; 23: 468-471
        • Piccolo R
        • Pilgrim T
        • Franzone A
        • Valgimigli M
        • Haynes A
        • Asami M
        • Lanz J
        • Räber L
        • Praz F
        • Langhammer B
        Frequency, timing, and impact of access-site and non–access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement.
        JACC: Cardiovasc Interv. 2017; 10: 1436-1446
        • Fowkes FGR
        • Rudan D
        • Rudan I
        • Aboyans V
        • Denenberg JO
        • McDermott MM
        • Norman PE
        • Sampson UKA
        • Williams LJ
        • Mensah GA
        • Criqui MH
        Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.
        Lancet. 2013; 382: 1329-1340
        • Gupta T
        • Goel K
        • Kolte D
        • Khera S
        • Villablanca PA
        • Aronow WS
        • Bortnick AE
        • Slovut DP
        • Taub CC
        • Kizer JR
        Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement.
        JACC: Cardiovasc Interv. 2017; 10: 2050-2060